Genetron Holdings Ltd. (GTH) Prices 16M ADS IPO at $16/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Genetron Health Announces Pricing of Initial Public Offering
June 19, 2020 8:45 AM EDTBEIJING, China, June 19, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (Genetron Health or the Company), a China-based precision oncology company that covers full-cycle cancer care, today announced the pricing of its initial public offering of 16,000,000 American Depositary Shares (ADSs), each representing five ordinary shares of the Company, at US$16.00 per ADS. The ADSs are expected to begin trading on the Nasdaq Global Market on June 19, 2020 under the symbol GTH. The gross proceeds from the initial public offering is US$256 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs. The Company has granted the... More
